Health care biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 health care biotech companies ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.5). Figures as of 19 Nov 2026, 23:07 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.3
Combined market value
R$4.89T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
Health Care
Biotech
BRL
Clear filters
Health care biotech companies by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7R$215.7BR$1,459.35 1.70% down 49% up United States
2QiagenQGEN · Health Care4.9R$60.5BR$293.08 0.14% up 9% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.5R$93.6BR$924.70 3.85% down 17% up United States
4BioNTechBNTX · Health Care6.3R$119.1BR$480.57 2.26% down 14% down Germany
5AmgenAMGN · Health Care6.5R$1.4TR$2,591.32 1.14% down 32% up United States
6ExelixisEXEL · Health Care6.9R$94.9BR$388.74 3.60% down 63% up United States
7Gilead SciencesGILD · Health Care7.0R$1.22TR$983.39 1.45% down 35% up United States
8Halozyme TherapeuticsHALO · Health Care7.6R$62.6BR$549.42 2.88% down 39% up United States
9Bio-TechneTECH · Health Care9.4R$67.4BR$429.31 0.07% down 24% up United States
10argenxARGX · Health Care14.3R$349.8BR$5,562.93 0.08% up 2% up Belgium
11RepligenRGEN · Health Care14.7R$64.3BR$1,005.60 1.38% down 12% up United States
12Adaptive BiotechnologiesADPT · Health Care16.4R$26.8BR$165.64 1.44% down 74% up United States
13Twist BioscienceTWST · Health Care20.2R$44.9BR$659.14 4.07% down 346% up United States
14Krystal BiotechKRYS · Health Care24.1R$55.3BR$1,864.98 0.15% up 54% up United States
15ModernaMRNA · Health Care41.5R$476.3BR$1,177.08 1.29% up 780% up United States
16ImmunityBioIBRX · Health Care61.7R$41.3BR$38.80 1.94% down 232% up United States
17Kymera TherapeuticsKYMR · Health Care260R$60.2BR$705.02 1.44% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1076R$22.3BR$229.89 3.14% down 18% down Switzerland
19CG OncologyCGON · Health Care1811R$43.2BR$483.64 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 5.9052 BRL). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which health care biotech companies have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.5) have the lowest P/S ratio of the 19 health care biotech companies ranked here as of 19 Nov 2026, 23:07 UTC.

How many health care biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 19 health care biotech companies ranked by P/S ratio have a combined market value of R$4.89T as of 19 Nov 2026, 23:07 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Health care biotech companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.